Showing results (51-60 of 73) with videos related to
Sort By:
Pageof 8
Cancer Research Communications|April 9, 2024
Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent "NoGlow" MiceTimothy N Trotter, Andrea Wilson, Jason McBane, et al.Cancer Research|May 6, 2020
IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with NeutrophilsTimothy N Trotter, Casey W Shuptrine, Li-Chung Tsao, et al.Cancer Immunology, Immunotherapy : CII|April 11, 2012
Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effectsTakuya Osada, Peter Berglund, Michael A Morse, et al.Oncoimmunology|July 7, 2017
Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibitionTakuya Osada, Michael A Morse, Amy Hobeika, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccineTakuya Osada, Christopher Y Woo, Matthew McKinney, et al.Journal for Immunotherapy of Cancer|April 1, 2022
Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpressionBin-Jin Hwang, Li-Chung Tsao, Chaitanya R Acharya, et al.Vaccine|October 18, 2011
Increasing vaccine potency through exosome antigen targetingZachary C Hartman, Junping Wei, Oliver K Glass, et al.Oncoimmunology|May 4, 2018
Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumorsErika J Crosby, Junping Wei, Xiao Yi Yang, et al.Molecular Cancer Therapeutics|February 22, 2012
Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancerMickey K Kim, Takuya Osada, William T Barry, et al.Communications Biology|May 10, 2020
Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumorsKensuke Kaneko, Takuya Osada, Michael A Morse, et al.Pageof 8